{"slug":"roche-scales-nvidia-ai-factories-globally-to-accelerate-drug-discovery-diagnostics-and-manufacturing","url":"https://findausecase.com/use-cases/roche-scales-nvidia-ai-factories-globally-to-accelerate-drug-discovery-diagnostics-and-manufacturing","title":"Roche scales NVIDIA AI factories globally to accelerate drug discovery, diagnostics and manufacturing","description":"Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on-premises environments in the U.S. and Europe, expanding an existing collaboration to turn AI and accelerated computing into a core operating capability across its pharmaceutical and diagnostics businesses. AI is central to Genentech's Lab-in-the-Loop drug discovery strategy, where nearly 90% of eligible small-molecule programs integrate AI; in one program a degrader molecule for oncology was designed 25% faster, and in another AI helped deliver a backup drug candidate in seven months instead of more than two years. Roche is also using NVIDIA Omniverse to build digital twins of manufacturing sites, including its new GLP-1 facility in North Carolina, uses NVIDIA Parabricks software to enable insights across vast datasets, is evaluating the BioNeMo platform for molecular design and chemistry innovation, and uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade AI.","company":"Roche","industry":"Pharmaceuticals","aiCapabilities":["Generative AI","Predictive Analytics","Computer Vision"],"businessFunctions":["Research & Development","Manufacturing & Production"],"technology":["NVIDIA Blackwell","NVIDIA BioNeMo","NVIDIA Omniverse","NVIDIA Parabricks","NVIDIA NeMo Guardrails"],"deployment":"Hybrid","problemStatement":"“When we talk about collapsing time, we’re really talking about the patients and their families who are waiting,” said Mamilli. “As an innovation-led company, using AI for this work is deeply meaningful and purpose-driven; it is exactly what we are here to do.”","solutionApproach":"Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on-premises environments in the U.S. and Europe, expanding on an existing collaboration to turn AI and accelerated computing into a core operating capability across its pharmaceutical and diagnostics businesses. With NVIDIA Blackwell and the NVIDIA BioNeMo platform running on its AI factories, Roche can train and fine-tune biological and molecular foundation models, integrate proprietary datasets and expand AI-driven lab automation, all powering Genentech's Lab-in-the-Loop drug discovery strategy. Roche is also modernizing pharmaceutical manufacturing with NVIDIA Omniverse libraries, building digital twins of production facilities to simulate and optimize complex systems before they go live, including its new GLP-1 manufacturing facility in North Carolina. Accelerated computing and NVIDIA Parabricks software enable insights across vast datasets, and in digital health Roche uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade AI.","businessValue":"Nearly 90% of Genentech's eligible small-molecule programs integrate AI. In one program, a degrader molecule for oncology was designed 25% faster, and in another program, AI helped deliver a backup molecule — a secondary drug candidate developed in parallel to mitigate costly risks of failure of the first one — in seven months instead of more than two years.","evidence":{"band":"high"},"sourceUrl":"https://blogs.nvidia.com/blog/roche-ai-factories-omniverse/","dates":{"publishedAt":"2026-08-30T09:04:21.279Z","publishedAtSource":"pipeline","updatedAt":"2026-08-30T09:04:21.279Z"},"license":"Open for reading and citing with a link to https://findausecase.com/use-cases/roche-scales-nvidia-ai-factories-globally-to-accelerate-drug-discovery-diagnostics-and-manufacturing. Bulk republication requires permission."}